Tags: drug | approval | diabetes | FDA

J&J Wins Approval for First in New Class of Diabetes Drugs

Friday, 29 Mar 2013 03:33 PM

Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs for managing blood sugar.

The Food and Drug Administration cleared the drug known as canagliflozin to treat adults with Type 2 diabetes, the agency said today in a statement. The pill may generate $800 million in peak sales, Tony Butler, an analyst at Barclays Plc in New York, said in a telephone interview.

The FDA is requiring J&J to conduct five post-marketing studies of the once-a-day pill to be called Invokana. The studies will examine the cardiovascular risks of the drug, as well as monitor for malignancies and severe cases of pancreatitis, the FDA said.

© Copyright 2015 Bloomberg News. All rights reserved.

1Like our page
2Share
Companies
Johnson & Johnson, the world's largest seller of health-care products, won approval for the first in a new family of diabetes drugs for managing blood sugar.
drug,approval,diabetes,FDA
117
2013-33-29
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved